Search
Powered By HealthLine
Health Tools
 Neurology Health Center
 Understanding Multiple Sclerosis
 Fibromyalgia Basics
 Video: Alzheimer's Disease
 Migraine - What is it?
Featured Conditions
 Alzheimer's
 Chronic Pain
 Multiple Sclerosis
 Depression
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Hope for Alzheimers Disease

Ivanhoe Newswire


Related Encyclopedia
 border=
Acoustic Neurinoma
Amenorrhea
Amniocentesis
Amniocentesis and CVS
More...

Related Healthscout Videos
 border=
Say Ahh! The First Oral Treatment for MS
Coming Around: Coma Breakthroughs
Baby Steps: Fertility Findings
Saving Memories with a Shake: The Alzheimer's Drink
More...

Related Animations
 border=
Breast Reduction
Breast Self-Exam Video
Erectile Dysfunction
Facelift
More...

Related Drug Information
 border=
Actonel
Adderal XR
Cialis
Concerta
More...

Related News Articles
 border=
Prenatal Antipsychotic Drugs Linked to Motor Delays: Study
Coffee Drinking in Pregnancy Won't Lead to Sleepless Baby: Study
1 in 5 Pharmacies Hinders Teens' Access to 'Morning-After' Pill: Study
'Freezing' Secondary Breast Cancer Tumors Shows Promise
More...

(Ivanhoe Newswire) -- A dramatic new video documents rapid improvement of language function of Alzheimers patients within minutes of using a new immune-based therapy.

Difficulty finding words is only one of many heartbreaking symptoms of advancing Alzheimers disease. In this latest study, researchers focused on the effect of the drug, etanercept (Enbrel), on measures of verbal ability. Documented on video, researchers found many patients, within minutes, saw dramatic improvement of their language function.

Text Continues Below



Etanercept is an anti-tumor necrosis factor-alpha (TNF-alpha) drug. TNF-alpha -- a critical component of the brains immune system -- normally finely regulates the transmission of neural impulses in the brain. In this study, researchers used a perispinal delivery method to deliver etanercept to reduce elevated levels of TNF-alpha.

"There are limitations to the data presented, Edward Tobinick, M.D., lead author of the study, was quoted as saying. The clinical trial was open label, and not controlled. These caveats notwithstanding, the scientific rationale for the further investigation of anti-TNF-alpha treatment of Alzheimer's disease is compelling. In addition, family members, independent neurologists, and other independent observers have confirmed the clinical, cognitive, and behavioral improvement noted".

Researchers say these results provide preliminary evidence that the disrupted neural communication seen in Alzheimer's disease may be reversible.

SOURCE: Journal of Neuroinflammation, 2008;8:27

Sign up for a free weekly e-mail on Medical Breakthroughs called First to Know by clicking here.

This article was reported by Ivanhoe.com, who offers Medical Alerts by e-mail every day of the week. To subscribe, go to: http://www.ivanhoe.com/newsalert/.




Last updated 7/28/2008

Related Links
 border=
From Healthscout's partner site on chronic pain, ChronicPainConnection.com
Find ways to get chronic pain relief!
Find a right treatment for your chronic pain
Join our community - your chronic pain support group.





HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2013. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire